PURPOSE2:
HIV Prevention Research
We need volunteers to help investigate a twice-yearly injection form of PrEP to see if it could reduce the chances of getting HIV through sex. Join our study!
Conducted in Greensboro, NC
16+ Years Old
No HIV Test in the Past 3 Months
Eligibility Requirements & Location
Having Receptive Anal Sex with 1 or More Partners
Study Background
Even though a variety of prevention options exist, HIV remains a serious health concern for many people around the world.

In the United States, socioeconomic inequity, racism, stigma, homophobia, transphobia, and other factors have led to higher rates of HIV in some communities. PURPOSE2 will test whether an investigational PrEP (pre-exposure prophylaxis) medicine lencapavir, helps reduce the chance of getting HIV through sex.

The study was designed to include groups who are underrepresented in HIV prevention trials and are disproportionately affected by the HIV epidemic.

PURPOSE2 is being conducted in the United States, South Africa, Peru, and Brazil, and will include cisgender men, transgender women, transgender men, and gender non-binary individuals who have sex with partners assigned male at birth.

Find out more about PURPOSE2 to see if you could be a part of advancing HIV prevention and changing medical research for the better.
Additional Information